Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Revenue (2016 - 2025)

Historic Revenue for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $134.3 million.

  • AtriCure's Revenue rose 1583.9% to $134.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $518.3 million, marking a year-over-year increase of 1580.35%. This contributed to the annual value of $465.3 million for FY2024, which is 1654.67% up from last year.
  • Per AtriCure's latest filing, its Revenue stood at $134.3 million for Q3 2025, which was up 1583.9% from $136.1 million recorded in Q2 2025.
  • AtriCure's 5-year Revenue high stood at $136.1 million for Q2 2025, and its period low was $59.3 million during Q1 2021.
  • Moreover, its 5-year median value for Revenue was $98.3 million (2023), whereas its average is $98.1 million.
  • Data for AtriCure's Revenue shows a peak YoY increase of 7483.83% (in 2021) and a maximum YoY decrease of 1136.68% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows AtriCure's Revenue stood at $73.2 million in 2021, then rose by 20.23% to $88.0 million in 2022, then increased by 21.03% to $106.5 million in 2023, then increased by 16.64% to $124.3 million in 2024, then rose by 8.04% to $134.3 million in 2025.
  • Its Revenue was $134.3 million in Q3 2025, compared to $136.1 million in Q2 2025 and $123.6 million in Q1 2025.